Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Long-Term Investments (2016 - 2024)

Marimed (MRMD) has disclosed Long-Term Investments for 10 consecutive years, with $274000.0 as the latest value for Q1 2024.

  • Quarterly Long-Term Investments changed N/A to $274000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $274000.0 through Mar 2024, changed N/A year-over-year, with the annual reading at $221000.0 for FY2023, N/A changed from the prior year.
  • Long-Term Investments for Q1 2024 was $274000.0 at Marimed, up from $221000.0 in the prior quarter.
  • The five-year high for Long-Term Investments was $2.5 million in Q1 2021, with the low at $89000.0 in Q2 2023.
  • Average Long-Term Investments over 5 years is $997690.0, with a median of $1.0 million recorded in 2020.
  • The sharpest move saw Long-Term Investments tumbled 97.1% in 2020, then surged 103.84% in 2021.
  • Over 5 years, Long-Term Investments stood at $1.2 million in 2020, then tumbled by 78.47% to $251000.0 in 2021, then skyrocketed by 439.04% to $1.4 million in 2022, then tumbled by 83.67% to $221000.0 in 2023, then grew by 23.98% to $274000.0 in 2024.
  • According to Business Quant data, Long-Term Investments over the past three periods came in at $274000.0, $221000.0, and $164000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.